[1]梁四妥,张西宁,庞彦英,等.氯替泼诺联合环孢素滴眼液治疗干燥综合征型干眼的疗效观察[J].眼科新进展,2014,34(11):1073-1076.[doi:10.13389/j.cnki.rao.2014.0298]
LIANG Si-Tuo,ZHANG Xi-Ning,PANG Yan-Ying,et al.Loteprednol Etabonate ophthalmic suspension with cyclosporine eye drops for dry eye of Sjogren ’ s syndrome[J].Recent Advances in Ophthalmology,2014,34(11):1073-1076.[doi:10.13389/j.cnki.rao.2014.0298]
点击复制
氯替泼诺联合环孢素滴眼液治疗干燥综合征型干眼的疗效观察
《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]
- 卷:
-
34卷
- 期数:
-
2014年11期
- 页码:
-
1073-1076
- 栏目:
-
应用研究
- 出版日期:
-
2014-11-05
文章信息/Info
- Title:
-
Loteprednol Etabonate ophthalmic suspension with cyclosporine eye drops for dry eye of Sjogren ’ s syndrome
- 作者:
-
梁四妥; 张西宁; 庞彦英; 韩二杰
-
061000 河北省沧州市,沧州眼科医院眼科
- Author(s):
-
LIANG Si-Tuo ; ZHANG Xi-Ning ; PANG Yan-Ying ; HAN Er-Jie
-
-
- 关键词:
-
氯替泼诺; 环孢素; 干燥综合征; 干眼
- Keywords:
-
Loteprednol ; cyclosporine ; Sjogren ’ s syndrome ; dry eye
- DOI:
-
10.13389/j.cnki.rao.2014.0298
- 文献标志码:
-
A
- 摘要:
-
目的 观察局部使用5g?L-1氯替泼诺滴眼液联合10g?L-1环孢素滴眼液治疗中重度干眼的安全性与疗效。方法 2013年1月至2014年1月,于我院门诊收集中重度干眼患者32例(64)眼,1g?L-1玻璃酸钠滴眼液每天4~8次作为基础用药,随机分为两组:试验组17例(34眼),予以5g?L-1氯替泼诺滴眼液滴眼,2周后改为5g?L-1氯替泼诺滴眼液联合10g?L-1环孢素滴眼液滴眼;对照组15例(30眼),予以5g?L-1氯替泼诺滴眼液滴眼。在治疗前及治疗后2、4、6、8周进行干眼症状问卷调查,行裂隙灯、泪膜破裂时间(break-uptime,BUT)、角膜荧光素染色(fluorescentstaining,FL)、SchirmerI试验(SchirmerItest,SIT)及非接触式眼压检查(non-contactintraocularpressuremeasurement,NCT)等。并对数据进行统计学分析。结果 两组患者治疗后2周、4周、6周、8周主观症状评分及FL评分均较治疗前明显降低,差异均有统计学意义(均为P<005)。治疗后4周、6周,对照组主观症状评分明显低于试验组,差异均有统计学意义(P=0.000、0.021),但治疗后8周,两组间差异无统计学意义(P=0.611)。治疗后6周对照组BUT较治疗前延长(P<0.05),治疗后8周两组BUT均较治疗前延长(P<0.05),各时间点两组间BUT差异均无统计学意义(均为P>0.05)。两组各时间点的SIT和NCT值较治疗前均无明显变化(均为P>0.05),各时间点组间差异均无统计学意义(均为P>0.05)。结论 对于中重度干燥综合征型干眼等慢性干眼患者采用局部5g?L-1氯替泼诺滴眼液预处理有助于减轻10g?L-1环孢素滴眼液所产生的刺痛,安全有效,又可避免长期应用其他类激素可能产生的不良反应。
- Abstract:
-
Objective To observe the efficacy and safety of 5 g . L-l Loteprednol Etabonate ophthalmic suspension with 10 g ’ L-l cyclosporine eye drops in the treatment of moderate and severe dry eye of Sjogren ’ s syndrome. Methods From January 2013 to January 2014 ,totally 32 dry eye patients( 64 eyes) in grade 2 0r grade 3 of Sjogren ’ s syndrome in our hospital were enrolled,l g . L-l sodium hyaluronate eye drops 4 - 8 times everyday was as the basis for medication.were randomly divided into two groups : In the experimental group ( 17 patients , 34 eyes ) , 5 g . L -1 loteprednol ophthalmic suspension was applied,5 g . L -1 loteprednol ophthalmic suspension combined with 10 g . L -l cyclosporine eye drops( bid) were applied 2 weeks later;ln the control group(15 cases.30 eyes) ,5 g ’ L-l loteprednol ophthalmic suspension was applied. Questionnaire was used in these patients before the treatment and repeated every 2 weeks during the treatment till 8 weeks. Slit lamp microscope exanunation . tear breakup time( BUT) .fluorescent staining ( FL) , Schirmer I test( SIt) and intraocular pressure measurement were carried out at the same time point. t test was used for statistical analysis. ReSHlts After 2 weeks ,4 weeks .6 weeks.8 weeks of the treatment.the mean scores of subjective symptom and FL were sigruficantly lower than those before the treatment in each group ( all P < 0. 05 ) . After 4 weeks.6 weeks of the treatment, the mean scores of subjective symptom were significantly lower in the control group than the experimental group (P = 0. 000 .0. 021 ) , but there was no significant difference between the two groups after 8 weeks of the treatment(P = 0. 611). After 6 weeks of the treatment.BUT was significantly prolonged in the control group compared with pretreatment ( P < 0. 05 ) . After 8 weeks . BUT was significantly prolonged in each group after the treatment ( P < 0. 05 ) . there was no significant difference between the two groups( all P > 0. 05 ) . There was no statistical difference in SIT and non-contact intraocular pressure between pre-treatment and post-treatment of two groups ( all P > 0. 05 ) . and no difference was also found at different time between two groups( all P > 0. 05) . Conclusion For chronic moderate to severe dry eye, such as Sjogren’ s syndrome patients, using topical 5 g . L-l loteprednol ophthalmic suspension in pre-treatment can reduce the stabbing pain produced by 10 g . L -l cyclosporine eye drops,is safe and effective , and also avoid adverse reactions produced by other hormones long-term application.
更新日期/Last Update:
2014-11-11